Gene526
ATP6V1B2: ATPase H+ transporting V1 subunit B2
Cite this record
ConductScience Library. ATP6V1B2: ATPase H+ transporting V1 subunit B2. Genes, record 526. Release gene-search-2026-11-13-0.2.1, 13 Nov 2026. https://conductscience.org/library/genes/526
- Sources
- 13 sources
- Release
- gene-search-2026-11-13-0.2.1
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P21281 | V-type proton ATPase subunit B, brain isoform | 511 | 8 | Ensembl, GeneID, HGNC |
Source UniProt
Patents74
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4755393 A1 | 2026-06-10 | 16 | P21281 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 2965 | P21281 | Espacenet |
| US 20250320254 A1 | 2025-10-16 | 2965 | P21281 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 2965 | P21281 | Espacenet |
| JP 2025062604 A | 2025-04-14 | 7479 | P21281 | Espacenet |
| US 20250084141 A1 | 2025-03-13 | 954 | P21281 | Espacenet |
| US 12227549 B2 | 2025-02-18 | 954 | P21281 | Espacenet |
| US 20240398993 A1 | 2024-12-05 | 7420 | P21281 | Espacenet |
| US 20240285795 A1 | 2024-08-29 | 119962 | P21281 | Espacenet |
| US 11884978 B2 | 2024-01-30 | 437 | P21281 | Espacenet |
NIH grants621
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | ATP6V1B2 papers | Newest fiscal year |
|---|---|---|---|
| P30CA016672 | Cancer Center Support Grant | 3 | 2025 |
| P30CA142543 | UT Southwestern Medical Center Simmons Comprehensive Cancer Center | 3 | 2025 |
| P30DK063491 | Diabetes Research Center (DRC) | 3 | 2025 |
| R35GM131919 | The mechanism and regulation of autophagy | 3 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 2 | 2025 |
| P30CA046592 | University of Michigan Rogel Cancer Center Support Grant 2023-2028 | 2 | 2025 |
| P30DK043351 | Center for the Study of Inflammatory Bowel Disease at Massachusetts General Hospital | 2 | 2025 |
| R25MH060482 | TRAINING THE NEXT GENERATION OF MENTAL HEALTH RESEARCHERS | 2 | 2025 |
| RM1HG009490 | Center for Genomic Editing and Recording: Development and Application of Next-Generation Genome and Epigenome Editing Methods to Advance the Study and Treatment of Human Disease | 2 | 2025 |
| T32AI060537 | Integrative Microbiology Program | 2 | 2025 |
Source NIH's project files
Papers575
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A TBK1/ULK1 signalling axis couples lysosomal stress to TFEB activation. | Nature | 2026 | 42816627 | PubTator, text mining | PubMed |
| Targeting the NR1D1-IGF2BP2-V-ATPase Axis With Hybrid Nanovesicles Restores Macrophage Rhythms to Reverse Sepsis-Induced Immunosuppression. | Adv Sci (Weinh) | 2026 | 42636084 | PubTator, text mining | PubMed |
| Mineral-driven molecular signatures of energy metabolism underpin sperm motility in buffalo. | Anim Reprod Sci | 2026 | 42612345 | PubTator, text mining | PubMed |
| The Converging Effects of Different Categories of Antidepressants on the Brain: A Systematic Meta-Analysis of Public Transcriptional Profiling Data From the Hippocampus and Cortex. | J Neurochem | 2026 | 42396602 | PubTator, text mining | PubMed |
| Hearing outcomes after cochlear implantation in two patients with ATP6V1B2-related deafness and onychodystrophy. | Eur J Med Genet | 2026 | 42361897 | PubTator, text mining | PubMed |
| Characterization of Lysosomal Hydrolases and Transporters and Their Age-Dependent Variability: Relevance to Drug Metabolism and Transport of Small Molecule and Biologic Drugs. | Clin Pharmacol Ther | 2026 | 42198901 | PubTator, text mining | PubMed |
| The Converging Effects of Different Categories of Antidepressants on the Brain: A Systematic Meta-Analysis of Public Transcriptional Profiling Data from the Hippocampus and Cortex. | bioRxiv | 2026 | 42146535 | PubTator, text mining | PubMed |
| ATP6V1B2 Regulating Autophagy Flux To Affect Abnormal Auditory Development. | Appl Biochem Biotechnol | 2026 | 41995948 | PubTator, text mining | PubMed |
| A pathogenic Tau mutation drives autophagy-lysosome dysfunction that limits Tau degradation in a model of frontotemporal dementia. | Nat Commun | 2026 | 41916975 | PubTator, text mining | PubMed |
| Investigation of cyanobacteria-hosted antibiotic resistance genes in cyanoHAB-impacted drinking water sources. | Environ Sci Pollut Res Int | 2026 | 41915265 | PubTator, text mining | PubMed |
None in this release
- Drugs
- Trials
Sources 13
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
- USPTO's sequence listingsPublic domain in the US. Source: United States Patent and Trademark Office, www.uspto.gov
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
- USPTO's sequence listingsUSPTO's sequence listings of patents and published applications, from its bulk data files. No license named for the files. USPTO's terms say "most government-produced materials appearing on this website are not subject to copyright restrictions within the United States and are therefore in the public domain", and ask that USPTO be given appropriate acknowledgement ("Source: United States Patent and Trademark Office, www.uspto.gov"). USPTO does not endorse ConductScience or this release. Read on 12 Nov 2026 at https://www.uspto.gov/terms-use-uspto-websites
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
Source: United States Patent and Trademark Office, www.uspto.gov. USPTO does not endorse ConductScience or this database.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/526
GET https://conductscience.org/api/genes/v1/526/patents?page=2